Cigna Corp (NYSE:CI) Position Boosted by Whitnell & Co.

Whitnell & Co. grew its holdings in shares of Cigna Corp (NYSE:CI) by 19.3% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 15,979 shares of the health services provider’s stock after purchasing an additional 2,587 shares during the period. Whitnell & Co.’s holdings in Cigna were worth $2,425,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also bought and sold shares of the company. Flagship Harbor Advisors LLC increased its position in Cigna by 13.9% during the second quarter. Flagship Harbor Advisors LLC now owns 1,089 shares of the health services provider’s stock worth $171,000 after acquiring an additional 133 shares during the period. Boenning & Scattergood Inc. boosted its stake in Cigna by 33.9% during the second quarter. Boenning & Scattergood Inc. now owns 2,370 shares of the health services provider’s stock worth $373,000 after buying an additional 600 shares in the last quarter. Daiwa Securities Group Inc. boosted its stake in Cigna by 2.0% during the second quarter. Daiwa Securities Group Inc. now owns 15,041 shares of the health services provider’s stock worth $2,370,000 after buying an additional 300 shares in the last quarter. Essex Savings Bank boosted its stake in Cigna by 48.7% during the second quarter. Essex Savings Bank now owns 4,829 shares of the health services provider’s stock worth $761,000 after buying an additional 1,581 shares in the last quarter. Finally, Bruni J V & Co. Co. boosted its stake in Cigna by 53.0% during the second quarter. Bruni J V & Co. Co. now owns 113,845 shares of the health services provider’s stock worth $17,936,000 after buying an additional 39,459 shares in the last quarter. Institutional investors own 87.40% of the company’s stock.

A number of equities research analysts have weighed in on the stock. Sanford C. Bernstein upgraded shares of Cigna from a “market perform” rating to an “outperform” rating and set a $205.00 price target on the stock in a research note on Tuesday, August 6th. Mizuho boosted their target price on shares of Cigna from $180.00 to $205.00 and gave the company a “buy” rating in a research note on Wednesday. Citigroup restated a “buy” rating and issued a $221.00 target price (up previously from $203.00) on shares of Cigna in a research note on Tuesday, November 5th. Deutsche Bank set a $210.00 target price on shares of Cigna and gave the company a “buy” rating in a research note on Friday, November 1st. Finally, UBS Group lifted their price target on Cigna from $214.00 to $222.00 and gave the company a “buy” rating in a report on Tuesday, November 5th. Three investment analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average target price of $213.84.

In other news, CEO David Cordani acquired 32,509 shares of the company’s stock in a transaction on Monday, September 9th. The stock was purchased at an average cost of $155.17 per share, with a total value of $5,044,421.53. Insiders own 0.80% of the company’s stock.

Shares of Cigna stock traded up $2.86 during trading on Friday, reaching $188.20. The company’s stock had a trading volume of 1,439,825 shares, compared to its average volume of 2,439,123. The stock has a 50-day moving average price of $163.40 and a two-hundred day moving average price of $160.81. The company has a current ratio of 0.63, a quick ratio of 0.63 and a debt-to-equity ratio of 0.76. Cigna Corp has a one year low of $141.95 and a one year high of $226.60. The stock has a market capitalization of $67.91 billion, a P/E ratio of 13.23, a price-to-earnings-growth ratio of 0.92 and a beta of 0.72.

Cigna (NYSE:CI) last released its quarterly earnings results on Thursday, October 31st. The health services provider reported $4.54 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $4.37 by $0.17. The business had revenue of $35.83 billion during the quarter, compared to analysts’ expectations of $34.20 billion. Cigna had a return on equity of 12.79% and a net margin of 3.30%. The firm’s revenue for the quarter was up 213.1% compared to the same quarter last year. During the same period in the previous year, the business posted $3.84 earnings per share. As a group, sell-side analysts anticipate that Cigna Corp will post 16.93 EPS for the current fiscal year.

Cigna Company Profile

Cigna Corporation, a health service organization, provides insurance and related products and services in the United States and internationally. It operates through Integrated Medical, Health Services, International Markets, and Group Disability and Other segments. The Integrated Medical segment offers medical, pharmacy, dental, behavioral health and vision, health advocacy programs, and other products and services to insured and self-insured clients; Medicare Advantage, Medicare Supplement, and Medicare Part D plans to Medicare-eligible beneficiaries, as well as Medicaid plans; and health insurance coverage to individual customers on and off the public exchanges.

Featured Article: What is Elliott Wave theory?

Institutional Ownership by Quarter for Cigna (NYSE:CI)

Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.